Follitropin Delta (REKOVELLE)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Follitropin Delta (REKOVELLE), covering 2023-08-31 to 2023-08-31. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation. [Phase 2]